Key result
Traumatizing events affect ~43% of VAD patients, but posttraumatic stress symptoms remain rare.
Why the study?
What is the prevalence of posttraumatic stress symptoms and traumatizing events in patients on ventricular assist device support?
Cross-Sectional (n=265)
Yes
What is the prevalence of posttraumatic stress symptoms and traumatizing events in patients on ventricular assist device support?
Answers are grounded in this paper and cite their sources.
A substantial proportion of VAD patients report traumatizing events, particularly related to heart surgery, highlighting the need for routine psychosocial screening.
Background Psychosocial outcome in ventricular assist device (VAD) patients continues to merit evaluation including posttraumatic stress symptoms (PTSS). Methods A cross‐sectional multicenter study collected data from 265 VAD patients, mean age was 59 ± 11yrs, 88% ( N = 234) were male. Standardized PRO measures were applied; PTSS was assessed with the Breslau scale, supplemented by open‐ended questions on “any traumatizing life events”. Results The weighted mean prevalence for patients reporting “any traumatizing event” was 43.0% (95% CI 37.0–49.2); prevalence for PTSS was 3.8% (95% CI 1.82–6.83). Traumatizing events were categorized into non‐heart‐related versus heart‐related (both n = 57; 50%); heart surgery ( n = 16) was most prominent. Oral intake of prescribed psychotropics (12.5%) was significantly higher in those with non‐heart‐related events (28.1% vs. 7.0%; p = 0.006). Female gender was associated with an OR of 1.703 (95%CI: 1.217–2.382; p = 0.002) for HADS depression and oral psychotropics (OR 6.623, 95%CI: 2.009–21.830; p = 0.002). HRQoL was lower for those on psychotropics ( p = 0.001). Patients who had experienced a trauma showed no differences in PTSS ( p = 0.771), anxiety ( p = 0.774), depression ( p = 0.565), and HRQoL ( p = 0.113). Conclusion A substantial proportion of VAD patients may have experienced traumatizing events; heart surgery was reported most prominently, may diminish the success of implantation, lead to PTSS, and warrants routine clinical screening of patients following VAD implantation.
No takes yet. Share an insight, caveat, or question.
Kugler et al. (2026) conducted a cross-sectional in Ventricular assist device (VAD) support (n=265). Traumatizing life events vs. No traumatizing life events was evaluated on Prevalence of any traumatizing event (95% CI 37.0-49.2). Among ventricular assist device patients, the prevalence of any traumatizing event was 43.0% (95% CI 37.0-49.2), while the prevalence of posttraumatic stress symptoms was 3.8%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: